dual orexin receptor antagonists (DORA) for treatment of insomnia in veterans population

Despite decades of effort, billions of dollars spent, and national attention, the suicide risk among post-9/11 veterans remains alarmingly elevated. Research shows that veterans who served in the Global War on Terror (GWOT) and subsequent campaigns face higher rates of suicidal behavior than many previous generations. One compelling answer lies at the intersection of moral injury, neuropsychiatric harm (linked to deployment logistics such as mandatory prophylactic drugs), a

After years of gridlock, the Merit Systems Protection Board (MSPB) —the independent federal agency that hears appeals from civil servants who believe they were unfairly disciplined, fired, denied reasonable accommodations, or retaliated against for whistleblowing—finally has a quorum again. For close to a decade, thousands of federal employee appeals have sat idle and have been teased by politicking because the Board lacked the three members to issue final decisions. But foll

On September 29, 2025, the Department of Veterans Affairs (VA) published a Proposed Rule (RIN 2900-AS37) in the Federal Register titled...

For much of the 1990s and early 2000s, the U.S. military issued mefloquine (Lariam) as a standard prophylactic against malaria for deployed service members. It was cheap, required only weekly dosing, and seemed convenient for large-scale use. But the true cost became clear later. Instead of simply preventing disease, mefloquine left thousands of veterans with lasting psychiatric and neurological injuries.

The U.S. Department of Veterans Affairs (“VA”) just published its Final Rule amending 38 C.F.R. § 17.417 that will allow VA clinicians...

Combat Veterans of America Announces Leadership Council to Strengthen Veteran Unity Nationwide